
                         Roanoke Times
                 Copyright (c) 1995, Landmark Communications, Inc.

DATE: WEDNESDAY, February 27, 1991                   TAG: 9102270562
SECTION: NATIONAL/INTERNATIONAL                    PAGE: A-5   EDITION: EVENING 
SOURCE: 
DATELINE: BALTIMORE                                LENGTH: Short

DRUG FIRM SAID TO GIVE FDA FALSE TEST PRODUCT

A pharmaceutical company has been charged with selling adulterated and mislabeled generic drugs, obstructing a Food and Drug Administration inquiry and lying to investigators, prosecutors said.

Bolar Pharmaceutical Co. of New York substituted brand-name drugs for its own during testing of its hypertension drug, Triamterene-Hydrochlorothiazide, according to the U.S. attorney. Between approval by the FDA in August 1987 and its withdrawal in January 1990, $140 million of the drug was sold, prosecutors said Tuesday.

The company faces a maximum $500,000 fine on each of 20 counts contained in a criminal information suit filed in U.S. District Court Tuesday, said Breckinridge Willcox, U.S. attorney for Maryland. - Associated Press

by CNB